{"contentid": 488661, "importid": NaN, "name": "Mestag teams up with Janssen in inflammatory disease", "introduction": "UK breakthrough inflammatory disease and immuno-oncology company Mestag Therapeutics has announced a target discovery, option and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.", "content": "<p>UK breakthrough inflammatory disease and immuno-oncology company Mestag Therapeutics has announced a target discovery, option and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson (NYSE: JNJ).</p>\n<p>The agreement, supported by Johnson &amp; Johnson Innovation, the US healthcare giant's strategic venture capital arm, will leverage Mestag&rsquo;s specialist fibroblast sub-population biology platform and data analytics to identify new therapeutic targets in the inflammatory disease space.</p>\n<p>Under the terms of the agreement, Mestag will interrogate fibroblast subpopulations across diseases and their interactions with key aspects of the immune system.</p>\n<p>The company grants to Janssen an option to an exclusive license to develop and commercialize therapeutics directed against up to two targets that may arise from the collaboration, in exchange for option fees, milestones, and royalties. Further financial terms were not disclosed.</p>\n<p>As part of the collaboration, David Lee, global immunology therapeutic area head, Janssen Research &amp; Development, will join Mestag&rsquo;s scientific advisory committee.</p>\n<p>Alongside the collaboration, Mestag will continue to develop the company&rsquo;s own inflammatory disease and cancer programs as it progresses its pipeline of first-in-class therapeutics towards the clinic.</p>\n<p>Susan Hill, chief executive of Mestag, said: &ldquo;Mestag&rsquo;s vision is to leverage our unique fibroblast biology platform and state-of-the-art data analytics to enable precision medicine breakthroughs in disease areas with high unmet medical need.</p>\n<p>&ldquo;We are delighted to validate our approach through this innovative partnership with Janssen and we look forward to working with the Janssen Research &amp; Development scientists to benefit patients.&rdquo;</p>", "date": "2021-05-18 15:23:00", "meta_title": NaN, "meta_keywords": "Janssen, Johnson, Mestag, disease, inflammatory, agreement, therapeutics, option, company, license, teams, immuno-oncology, announced, breakthrough, Biotec", "meta_description": "UK breakthrough inflammatory disease and immuno-oncology company Mestag Therapeutics has announced a target discovery, option and license agreement with Janssen", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-18 15:16:57", "updated": "2021-05-18 16:07:48", "access": NaN, "url": "https://www.thepharmaletter.com/article/mestag-teams-up-with-janssen-in-inflammatory-disease", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "mestag_large.png", "image2id": "mestag_small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Inflammatory diseases", "topic_tag": "Deals, Focus On, Licensing, One to Watch Companies, Research", "geography_tag": "USA", "company_tag": "Janssen, Johnson & Johnson, Mestag Therapeutics", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-18 15:23:00"}